in the Lab

Identifying symptoms and signals is the crucial first step in any investigation. Symptoms of edge lifting after adhesive change can manifest in various ways:

• Visual Inspection: Clear evidence of lifting at the edges of the transdermal patches, which can be observed during quality checks prior to release.
• Performance Metrics: Increased rates of Out-of-Specification (OOS) results during stability studies related to adhesion strength and skin adherence.
• Customer Complaints: Reports of user feedback indicating the patch does not adhere properly during wear, affecting user satisfaction.
• Batch Records: Discrepancies in the production logs compared to previous batches that did not exhibit such issues.

These symptoms should prompt an immediate investigation to determine the root cause of the deviation. Furthermore, they will guide subsequent steps to ensure that quality systems effectively address the issue.

Likely Causes

The likely causes of edge lifting can be categorized according to the “5M” framework: Materials, Method, Machine, Man, and Measurement.

Category	Likely Causes
Materials	Change in adhesive formulation, incompatibility with backing materials, quality of raw materials, storage conditions prior to use.
Method	Inadequate application techniques, incorrect curing or drying times, improper handling procedures during assembly.
Machine	Equipment calibration issues, wear and tear on application machinery, build-up of adhesive residues on equipment.
Man	Lack of training or awareness related to new materials, human error during the application or inspection phases.
Measurement	Inaccurate adhesion measurement techniques, inconsistency in test conditions during performance assessments.

By categorizing potential causes, you can create a focused investigation plan that addresses each area systematically.

Immediate Containment Actions (first 60 minutes)

In the event of identifying edge lifting as a critical deviation, immediate containment actions are necessary to assess and mitigate the impact:

1. Quarantine Affected Batches: Immediately isolate any batches of the transdermal system suspected of exhibiting edge lifting or functionality issues.
2. Notify Relevant Stakeholders: Inform cross-functional teams, including production, quality control, and regulatory affairs, about the incident to ensure a unified response.
3. Suspension of Further Production: Halt production of similar products using the new adhesive until a thorough investigation concludes.
4. Initial Inspection: Perform a visual and functional check on the affected products and batch records. Document any signs of deviation for future reference.
5. Communication with Customers: If applicable, prepare a communication strategy to inform any affected customers about potential issues and next steps.

Taking prompt action is crucial to minimizing potential harm, controlling costs associated with the defect, and maintaining consumer confidence.

Investigation Workflow

Establishing a clear workflow for investigating edge lifting incidents is key. This workflow typically includes the following steps:

1. Data Collection: Gather data from various sources including production logs, quality control testing results, batch records, and any customer complaints related to the issue.
2. Analysis of Variability: Compare the affected batch data against historical data for previous batches that did not exhibit similar issues to identify any notable differences.
3. Conduct Interviews: Speak with manufacturing personnel, quality control staff, and others involved in the process to gain insights about any anomalies at the time of production.
4. Document Findings: Clearly document all findings, discrepancies, assumptions, and conclusions derived from the data and interviews.
5. Initial Assessment of Impact: Evaluate the impact of the identified issues on both product quality and regulatory compliance.

This structured approach will help narrow down the possible causes based on evidence collected from various data sources.

Root Cause Tools

To ascertain the root cause of edge lifting, employing root cause analysis tools is essential. Here are three effective methods:

5-Why Analysis

This technique involves asking “Why?” repeatedly (typically five times) to drill down to the fundamental cause of a problem. It’s particularly effective for simple problems with a clear causative pathway.

Fishbone Diagram

A Fishbone diagram, or Ishikawa diagram, visually maps out potential causes in categories, aiding teams in brainstorming and organizing thoughts around the problem. This tool is ideal when investigating complex issues with multiple potential factors.

Fault Tree Analysis

Fault Tree Analysis (FTA) is a top-down, deductive analysis method used to determine the root causes of system failures. It’s particularly useful for more systematic and critical evaluations wherein probability and risk are assessed.

Choose the most suitable tool based on the complexity of the investigation and the clarity of potential contributing factors.

CAPA Strategy

Once the root cause(s) are identified, developing a robust CAPA strategy is critical. This involves three key steps:

Correction

Implement immediate corrective actions to address any non-conformances found during the investigation. This could involve re-evaluating the adhesive application process or restoring previous adhesive formulations pending revalidation.

Related Reads

• Dosage Form Failures and Poor Bioavailability? Practical Drug Delivery Solutions Across Forms

Corrective Action

Develop actionable steps that prevent recurrence of the issue. For instance, enhanced training for personnel, revising standard operating procedures (SOPs), or modifying the adhesive change control process could be required.

Preventive Action

Further expand your CAPA to include preventive measures that address root causes. This may involve implementing new equipment maintenance schedules, additional testing before batch releases, or revisiting material supplier agreements to ensure adherence to specifications.

Control Strategy & Monitoring

Establishing a control strategy for monitoring future batches is vital in preventing recurrences:

• Statistical Process Control (SPC): Implement SPC to monitor adhesion characteristics in real-time, providing immediate feedback if deviations occur.
• Regular Sampling: Increase the frequency of quality control testing on batches produced with new adhesives to promptly catch any variations.
• Alarms and Alerts: Develop alarm systems within production units to track deviations in application processes or material usage.
• Verification: Include enhanced verification steps in Quality Assurance to confirm that all new materials undergo thorough evaluation before use.

Continuous monitoring will create a proactive environment aimed at sustaining product quality standards.

Validation / Re-qualification / Change Control Impact

Any change in adhesive formulation necessitates thorough validation or re-qualification of the entire production process. This includes:

• Re-evaluation of existing validation protocols: Verify that changes align with regulatory requirements and that all parameters are adequately captured.
• Change Control Processes: Ensure adherence to change control procedures as stipulated by regulatory guidelines, including FDA’s guidance on control of manufacturing changes.
• Impact Assessment: Assess whether changes necessitate updates in filing with regulatory bodies or if notifications are required to clients and stakeholders.

Establishing robust change control procedures not only aids in regulatory compliance but also fortifies overall operational effectiveness.

Inspection Readiness: What Evidence to Show

During a regulatory inspection (such as by the FDA, EMA, or MHRA), being well-prepared is paramount. The following documentation should be readily available:

• Records of Investigations: Complete investigation reports generated during the edge lifting incident investigation.
• Batch Production Records: Records showing the production parameters for affected batches, including any deviations.
• CAPA Documentation: Evidence of implemented corrective actions, including follow-ups and their outcomes.
• Training Records: Documentation of any training initiated related to changes in procedure or materials.
• Change Control Records: Logs of all changes made to adhesives and other materials, supported by validation assessments.

Having this information organized and easily accessible will facilitate a smooth inspection experience and demonstrate a commitment to compliance.

FAQs

What is edge lifting in transdermal patches?

Edge lifting refers to the separation of the edges of transdermal patches from the skin, often leading to decreased efficacy of the product.

What causes edge lifting after adhesive changes?

Causes can include formulation issues, improper application techniques, or non-compliance with manufacturing processes.

How can I contain an edge lifting issue quickly?

Immediate actions include quarantining affected batches, notifying relevant teams, and halting further production until the issue is resolved.

What tools should I use during a root cause analysis?

Tools such as 5-Why analysis, Fishbone diagrams, and Fault Tree Analysis are effective in identifying root causes.

What should be included in a CAPA plan?

A CAPA plan should include corrective actions, plans for long-term corrective actions, and preventive actions to avoid recurrence of the issue.

How do I validate a new adhesive material?

Validation should encompass assessments of performance, stability testing, and confirming compliance with regulatory standards.

What documentation is needed for regulatory inspections?

Be prepared to provide investigation reports, batch production records, CAPA documentation, training records, and change control records.

How often should I monitor and analyze adhesive performance?

Implement continuous monitoring mechanisms to provide real-time feedback, and conduct in-depth analyses regularly during stability and performance testing.